Concepedia

Suresh Veeramani

SV

Statistics

Publications

16

Citations

816

H-Index

13

Active since

2005

Affiliations

University of Nebraska Medical Center(Current)

University of Iowa

Nagasaki University

Creighton University

Kaohsiung Medical University

Suresh Veeramani is an author at University of Nebraska Medical Center specializing in oncology, life sciences, and cancer cell signaling.

ORCID

Publications per year

2005–2024

16

Publications

16

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells

Ta‐Chun Yuan, Suresh Veeramani, Fen-Fen Lin et al. · Endocrine Related Cancer · 2006 · 176 citations · Full text

, , +12

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model

Siao‐Yi Wang, Suresh Veeramani, Emilian Racila et al. · Blood · 2009 · 135 citations · Full text

, , +16

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

Suresh Veeramani, Siao‐Yi Wang, Christopher E. Dahle et al. · Blood · 2011 · 121 citations · Full text

, , +16

Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells

Suresh Veeramani, T-C Yuan, F-F Lin et al. · Oncogene · 2008 · 76 citations · Full text

, , +16

Expression of p66Shc protein correlates with proliferation of human prostate cancer cells

Suresh Veeramani, Tsukasa Igawa, Ta‐Chun Yuan et al. · Oncogene · 2005 · 59 citations

, , +9

1–5 of 16